CoChat

Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients

Open access
Mann, Nina, Braun, Daniela A., Amann, Kassaundra, Tan, Weizhen, Shril, Shirlee, Connaughton, Dervla M., Nakayama, Makiko, Schneider, Ronen, Kitzler, Thomas M., van der Ven, Amelie T., Chen, Jing, Ityel, Hadas, Vivante, Asaf, Majmundar, Amar J., Daga, Ankana, Warejko, Jillian K., Lovric, Svjetlana, Ashraf, Shazia, Jobst-Schwan, Tilman, Widmeier, Eugen, Hugo, Hannah, Mane, Shrikant M., Spaneas, Leslie, Somers, Michael J.G., Ferguson, Michael A., Traum, Avram Z., Stein, Deborah R., Baum, Michelle A., Daouk, Ghaleb H., Lifton, Richard P., Manzi, Shannon, Vakili, Khashayar, Kim, Heung Bae, Rodig, Nancy M., Hildebrandt, Friedhelm · 2019 · Journal of the American Society of Nephrology
Cited by 157

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Significance Statement: Case reports describe scenarios in which previously undiagnosed genetic disorders, such as primary hyperoxaluria type 1, caused early allograft failure in kidney transplant recipients. Whole-exome sequencing (WES) has found that approximately 20% of pediatric patients with CKD have a relevant mutation, but the diagnostic yield of WES in kidney transplant recipients is not known. In this study of 104 kidney transplant recipients at a single center, use of WES provided a molecular genetic diagnosis for 34 out of 104 (32.7%) patients. Such diagnoses enabled identification of potential prospective consequences for many patients; in others, receiving the diagnosis earlier in the course of their disease might have mitigated negative consequences. The authors propose considering WES for any child or young adult with CKD. Background: Whole-exome sequencing (WES) finds a CKD-related mutation in approximately 20% of patients presenting with CKD before 25 years of age. Although provision of a molecular diagnosis could have important implications for clinical management, evidence is lacking on the diagnostic yield and clinical utility of WES for pediatric renal transplant recipients. Methods: To determine the diagnostic yield of WES in pediatric kidney transplant recipients, we recruited 104 patients who had received a transplant at Boston Children’s Hospital from 2007 through 2017, performed WES, and analyzed results for likely deleterious variants in approximately 400 genes known to cause CKD. Results: By WES, we identified a genetic cause of CKD in 34 out of 104 (32.7%) transplant recipients. The likelihood of detecting a molecular genetic diagnosis was highest for patients with urinary stone disease (three out of three individuals), followed by renal cystic ciliopathies (seven out of nine individuals), steroid-resistant nephrotic syndrome (nine out of 21 individuals), congenital anomalies of the kidney and urinary tract (ten out of 55 individuals), and chronic glomerulonephritis (one out of seven individuals). WES also yielded a molecular diagnosis for four out of nine individuals with ESRD of unknown etiology. The WES-related molecular genetic diagnosis had implications for clinical care for five patients. Conclusions: Nearly one third of pediatric renal transplant recipients had a genetic cause of their kidney disease identified by WES. Knowledge of this genetic information can help guide management of both transplant patients and potential living related donors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1681/asn.2018060575

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 157

Metadata

Authors
Mann, N., Braun, D. A., Amann, K., Tan, W., Shril, S., Connaughton, D. M., Nakayama, M., Schneider, R., Kitzler, T. M., van der Ven, A. T., Chen, J., Ityel, H., Vivante, A., Majmundar, A. J., Daga, A., Warejko, J. K., Lovric, S., Ashraf, S., Jobst-Schwan, T., Widmeier, E., Hugo, H., Mane, S. M., Spaneas, L., Somers, M. J. G., Ferguson, M. A., Traum, A. Z., Stein, D. R., Baum, M. A., Daouk, G. H., Lifton, R. P., Manzi, S., Vakili, K., Kim, H. B., Rodig, N. M., & Hildebrandt, F.
Venue
Journal of the American Society of Nephrology
Published
2019-01-17
Volume
30
Issue
2
Pages
201-215
ISSN
  • 1046-6673 (ISSN-L)
  • 1533-3450
OpenAlex
W2908533512
Cited by
157
References
3
FWCI
10.84
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients. https://app.cochat.ai/papers/10.1681/asn.2018060575
The paper
Mann, N., Braun, D. A., Amann, K., Tan, W., Shril, S., Connaughton, D. M., Nakayama, M., Schneider, R., Kitzler, T. M., van der Ven, A. T., Chen, J., Ityel, H., Vivante, A., Majmundar, A. J., Daga, A., Warejko, J. K., Lovric, S., Ashraf, S., Jobst-Schwan, T., . . . Hildebrandt, F. (2019). Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2018060575

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.